BIOMAT Database Logo BIOMAT Database Logo

Sequence and expression of Tangier apoA-I gene. 1988

S C Makrides, and N Ruiz-Opazo, and M Hayden, and A L Nussbaum, and J L Breslow, and V I Zannis
Department of Medicine, Boston University Medical Center, Massachusetts 02118.

We have isolated and characterized the apoA-I gene from a lambda L47.1 genomic library constructed with DNA obtained from the lymphocytes of a Tangier disease patient. The DNA-derived protein sequence of Tangier apoA-I was found to be identical to normal apoA-I. Transfection of mouse C127 cells with a recombinant vector containing the Tangier apoA-I gene (pSV2-gpt apoA-I) allowed selection of stable clones resistant to aminopterin and mycophenolic acid. Analysis of these clones for apoA-I synthesis showed that the protein secreted by cells expressing the Tangier apoA-I gene was indistinguishable from the apoA-I secreted by HepG2 cells. These experiments establish that the Tangier apoA-I gene is structurally normal. It appears that the molecular basis of Tangier disease is not related to apoA-I structure or regulation of expression, but rather to other factors pertinent to apoA-I and high-density lipoprotein metabolism.

UI MeSH Term Description Entries
D007009 Hypolipoproteinemias Conditions with abnormally low levels of LIPOPROTEINS in the blood. This may involve any of the lipoprotein subclasses, including ALPHA-LIPOPROTEINS (high-density lipoproteins); BETA-LIPOPROTEINS (low-density lipoproteins); and PREBETA-LIPOPROTEINS (very-low-density lipoproteins). Hypolipoproteinemia,Hypoprebetalipoproteinemia
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

S C Makrides, and N Ruiz-Opazo, and M Hayden, and A L Nussbaum, and J L Breslow, and V I Zannis
Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).
April 1982, Proceedings of the National Academy of Sciences of the United States of America,
S C Makrides, and N Ruiz-Opazo, and M Hayden, and A L Nussbaum, and J L Breslow, and V I Zannis
Sequence of the porcine apoA-I gene.
December 1993, Gene,
S C Makrides, and N Ruiz-Opazo, and M Hayden, and A L Nussbaum, and J L Breslow, and V I Zannis
Type 1 Deiodinase Regulates ApoA-I Gene Expression and ApoA-I Synthesis Independent of Thyroid Hormone Signaling.
July 2016, Arteriosclerosis, thrombosis, and vascular biology,
S C Makrides, and N Ruiz-Opazo, and M Hayden, and A L Nussbaum, and J L Breslow, and V I Zannis
POPC/apoA-I discs as a potent lipoprotein modulator in Tangier disease.
March 2008, Atherosclerosis,
S C Makrides, and N Ruiz-Opazo, and M Hayden, and A L Nussbaum, and J L Breslow, and V I Zannis
Differential tissue-specific expression of human apoA-I and apoA-II.
May 1991, Journal of lipid research,
S C Makrides, and N Ruiz-Opazo, and M Hayden, and A L Nussbaum, and J L Breslow, and V I Zannis
Tissue-specific expression of apolipoprotein A-I (ApoA-I) is regulated by the 5'-flanking region of the human ApoA-I gene.
December 1988, The Journal of biological chemistry,
S C Makrides, and N Ruiz-Opazo, and M Hayden, and A L Nussbaum, and J L Breslow, and V I Zannis
Regulation of apoA-I gene expression: mechanism of action of estrogen and genistein.
January 2004, Journal of lipid research,
S C Makrides, and N Ruiz-Opazo, and M Hayden, and A L Nussbaum, and J L Breslow, and V I Zannis
ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR.
August 2000, Biochemical and biophysical research communications,
S C Makrides, and N Ruiz-Opazo, and M Hayden, and A L Nussbaum, and J L Breslow, and V I Zannis
Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent.
May 2007, Cardiovascular diabetology,
S C Makrides, and N Ruiz-Opazo, and M Hayden, and A L Nussbaum, and J L Breslow, and V I Zannis
cDNA cloning of human apoA-I: amino acid sequence of preproapoA-I.
April 1983, Biochemical and biophysical research communications,
Copied contents to your clipboard!